0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Recombinant Protein > Human Cell Expressed > Rat THY1 Protein (His Tag)

Rat THY1 Protein (His Tag) PDF Download

Catalog Size (Price) Quantity In Stock Operation Other Information
80337-R08H
  YES          

Protein Production & Purification Service

Thy-1 cell surface antigen Protein Datasheet

 

THY1 Protein Price Inquiry ( Available Sizes )

THY1 Protein Product Information

Synonym : THY1, Thy-1
Protein Construction:

A DNA sequence encoding the rat THY1 (P01830)(Met1-Lys129) was expressed with a polyhistidine tag at the C-terminus.

Source: Rat
Expression Host: Human Cells

THY1 Protein QC Testing

Purity: > 95 % as determined by SDS-PAGE SDS-PAGE:
SDS-PAGE

THY1 protein

Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method
Stability: Samples are stable for up to twelve months from date of receipt at -70℃
Predicted N terminal: Gln 20
Molecular Mass:

The recombinant rat THY1 comprises 121 amino acids and predicts a molecular mass of 14.1 kDa. The apparent molecular mass of  the recombinant protein is approximately 27-29 kDa in SDS-PAGE under reducing conditions due to glycosylation.

Formulation: Lyophilized from sterile PBS, pH7.4.
  1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
  2. Please contact us for any concerns or special requirements.

THY1 Protein Usage Guide

Storage: Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution: A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

THY1 Protein Related Products & Topics

Related Areas:

Biomarkers>>Neuronal Cell Markers>>CD90/THY-1

Immunology>>Adaptive Immunity>>Costimulation & Costimulatory Molecule>>CD90/THY-1

Immunology>>Cluster of Differentiation>>Hematopoietic Stem Cell CD Marker>>CD90/THY-1

Proteins:

Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
CD90/THY-1 Mouse CD90/THY1 Protein, Recombinant 50461-M08H
CD90/THY-1 Rat THY1 Protein, Recombinant 80337-R08H

Antibodies:

Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Mouse
CD90/THY-1
WB, ELISA CD90/THY-1 Antibody, Rabbit PAb 50461-RP01
Mouse
CD90/THY-1
WB, ELISA CD90/THY-1 Antibody, Rabbit PAb (Antigen Affinity Purified) 50461-RP02

THY1 Protein Description

Thy-1 membrane glycoprotein, also known as Thy-1 antigen, CD90 and THY1, is a cell membrane protein which contains 1 Ig-like V-type (immunoglobulin-like) domain. THY1 / CD90, a member of the immunoglobulin superfamily of adhesion molecules with constitutive expression on fibroblast cells. THY1 / CD90 is a cell surface glycoprotein originally identified on mouse thymocytes. It has been identified on a variety of stem cells and at varying levels in non-lymphoid tissues such as on fibroblasts, brain cells, and activated endothelial cells. THY1 / CD90 is a membrane glycoprotein expressed in thymus, retinal ganglionic cells, and several types of stem cells. It was observed that THY1 / CD90 cell surface expression decreased significantly during the course of infection. In adult rats, expression of THY1 / CD90 on the B cell lineage is confined to immature B cells. The expression of THY1 / CD90 on neonatal MZ-B cells may have implications for their responsiveness to polysaccharide (T cell-independent type 2) antigens. THY1 / CD90 is modulated following infection with Human cytomegalovirus (HCMV). Neuroblastoma (NBL) is the most common solid tumor in children. THY1 / CD90 seemed to be a marker with a specific prognostic value in NBL patients. THY1 / CD90 may also play a role in cell-cell or cell-ligand interactions during synaptogenesis and other events in the brain.

References

  1. Dammers PM. et al., 2002, Dev Immunol. 9 (4): 187-95.
  2. Leis M. et al., 2004, J Gen Virol. 85 (7): 1995-2000.
  3. Wiesmann A. et al., 2006, Head Face Med. 2: 8.
  4. Fiegel HC. et al., 2008, Pediatr Surg Int. 24 (1): 101-5.
  5. Kisselbach L. et al., 2009, Cytotechnology. 59 (1): 31-44.